Cross Country Healthcare Sees Q3 2024 Adj. EPS $0.08-$0.12 Vs $0.13 Estimate
Portfolio Pulse from Benzinga Newsdesk
Cross Country Healthcare has provided guidance for Q3 2024 adjusted EPS in the range of $0.08 to $0.12, which is below the analyst estimate of $0.13.
July 31, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare's guidance for Q3 2024 adjusted EPS is below analyst expectations, which could negatively impact the stock price in the short term.
The company's guidance for Q3 2024 adjusted EPS is lower than the analyst estimate, which typically leads to a negative market reaction as it indicates potential underperformance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100